UCB.BR
Ucb SA
Price:  
264.50 
EUR
Volume:  
241,891.00
Belgium | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

UCB.BR WACC - Weighted Average Cost of Capital

The WACC of Ucb SA (UCB.BR) is 8.4%.

The Cost of Equity of Ucb SA (UCB.BR) is 8.65%.
The Cost of Debt of Ucb SA (UCB.BR) is 4.25%.

Range Selected
Cost of equity 7.30% - 10.00% 8.65%
Tax rate 14.20% - 15.80% 15.00%
Cost of debt 4.00% - 4.50% 4.25%
WACC 7.1% - 9.8% 8.4%
WACC

UCB.BR WACC calculation

Category Low High
Long-term bond rate 2.9% 3.4%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.74 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 10.00%
Tax rate 14.20% 15.80%
Debt/Equity ratio 0.04 0.04
Cost of debt 4.00% 4.50%
After-tax WACC 7.1% 9.8%
Selected WACC 8.4%

UCB.BR's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for UCB.BR:

cost_of_equity (8.65%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.74) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.